RPG Life Sciences Complete Financial Statements
In FY2026, RPG Life Sciences (RPGLIFE) reported revenue ₹190 Cr, net profit ₹30 Cr and EPS ₹18.08, with a net profit margin of 15.8% and ROE of 5.0%. Full financial statements from FY2024 to FY2026 (3 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine RPGLIFE earnings report for recent quarterly revenue, profit and EPS trends.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
RPGLIFE Revenue, Net Profit & EBITDA — Year-on-Year Growth
RPGLIFE YoY (Mar 2025 vs Mar 2026) — revenue -26.4%, net profit -74.4%, EBITDA -67.1%, expenses +22.0%. Analyse RPGLIFE shareholder distribution to track promoter, FII and institutional holdings.
RPGLIFE Income Statement — Revenue, EBITDA & Net Profit
RPG Life Sciences revenue ₹190 Cr, EBITDA ₹46 Cr, net profit ₹30 Cr, EPS ₹18.08 (2026) — net profit margin 15.8%. For live price, earnings ratios and company overview, see RPG Life Sciences share price chart.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Revenue | 190 | 197 | 258 | 166 | 183 | 176 |
| Expenses | 144 | 143 | 118 | 125 | 149 | 124 |
| EBITDA | 46 | 55 | 140 | 41 | 35 | 53 |
| Operating Profit Margin % | 19.00% | 21.00% | 18.00% | 26.00% | 17.00% | 28.00% |
| Depreciation | 6 | 5 | 5 | 5 | 5 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 40 | 50 | 135 | 35 | 29 | 47 |
| Tax | 10 | 13 | 18 | 9 | 7 | 12 |
| Net Profit | 30 | 37 | 117 | 26 | 22 | 35 |
| Earnings Per Share (₹) | 18.08 | 22.28 | 70.96 | 15.90 | 13.38 | 21.12 |
RPGLIFE Balance Sheet — Assets, Liabilities & Shareholders' Equity
RPGLIFE total assets ₹793 Cr, total equity ₹605 Cr, total liabilities ₹ Cr (2026) — ROE 5.0%.
| Particulars | 2026 | 2025 |
|---|---|---|
| ASSETS | ||
| Total Assets | 793 | 658 |
| Current Assets | 560 | 465 |
| Fixed Assets | 197 | 172 |
| Capital Work in Progress | 23 | 16 |
| Investments | 85 | 127 |
| Other Assets | 488 | 343 |
| LIABILITIES | ||
| Total Liabilities | ||
| Current Liabilities | 27 | 7 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 605 | 531 |
| Share Capital | 13 | 13 |
| Reserves & Surplus | 592 | 517 |
RPGLIFE Cash Flow Statement — Operating, Investing & Financing
RPG Life Sciences operating cash flow ₹57 Cr, investing ₹86 Cr, financing ₹-21 Cr, net cash flow ₹122 Cr (2026).
| Particulars | March 2026 | March 2025 |
|---|---|---|
| Operating Activities | 57 | 78 |
| Investing Activities | 86 | -42 |
| Financing Activities | -21 | -27 |
| Net Cash Flow | 122 | 9 |